Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study
Tóm tắt
Despite significant advances in antiemetic management, almost 50% of cancer patients still experience nausea and vomiting during treatment. The goal of antiemetic therapy is complete prevention of treatment-induced nausea and/or vomiting (TINV); however, realisation of this goal remains elusive, thus supplementary strategies identifying patients at high risk must be employed in the interim. Consequently, we examined TINV incidence and its risk factors, including patient, clinical and pretreatment quality of life (QOL)/psychological factors. Two hundred newly diagnosed cancer patients beginning combined treatment participated in this prospective, longitudinal, observational study. QOL (including TINV), psychological adjustment, and patient/clinical characteristics were examined at pretreatment, on-treatment (8 weeks ± 1 week) and post-treatment. Overall, 62% of patients experienced TINV, with TIN incidence (60%) doubling that of TIV (27%). Eight independent risk factors predicted 73% of TIN incidence: high premorbid/anticipatory NV, moderately/highly emetogenic chemotherapy (M/HEC), longer treatment (>3 months), female gender, surgery prior to adjuvant chemotherapy ± radiotherapy, private health insurance and low emotional functioning (pretreatment). Six independent risk factors predicted 77% of TIV incidence: premorbid/anticipatory vomiting, M/HEC, female gender, cancer resection and low role functioning (pretreatment). TINV still represents a very major concern for patients. Several pretreatment risk factors for the development of TIN and TIV, respectively, were identified. Patients about to undergo cancer treatment, particularly combined treatment involving emetogenic chemotherapy and surgery, should be screened for these factors with a view to modifying standard pretreatment/maintenance antiemetic therapy. Furthermore, and consistent with recent research, it is recommended that more comprehensive interventions combining antiemetics with other effective pharmacological (e.g. anxiolytics) and non-pharmacological approaches (e.g. acupuncture, relaxation techniques) be considered by clinicians in attempts to improve control of TIN and TIV (and overall QOL) for their patients. In this way, optimal holistic care will be ensured for cancer patients by clinicians providing conventional oncology treatment.
Tài liệu tham khảo
citation_journal_title=Eur J Cancer Clin Oncol; citation_title=On the receiving end—patient perception of the side-effects of cancer chemotherapy; citation_author=AS Coates, S Abraham, SB Kaye, T Sowerbutts, C Frewin, RM Fox, MH Tattersall; citation_volume=19; citation_publication_date=1983; citation_pages=203-208; citation_doi=10.1016/0277-5379(83)90418-2; citation_id=CR1
citation_journal_title=J Clin Oncol; citation_title=The influence of symptoms of disease and side effects on treatment compliance with cancer therapy; citation_author=J Richardson, G Marks, A Levine; citation_volume=5; citation_publication_date=1988; citation_pages=1746-1752; citation_id=CR2
citation_journal_title=Ann Oncol; citation_title=On the receiving end. V: patient perceptions of the side-effects of cancer chemotherapy in 1993; citation_author=AM Griffin, PN Butow, AS Coates, AM Childs, PM Ellis, SM Dunn, MH Tattersall; citation_volume=7; citation_issue=2; citation_publication_date=1996; citation_pages=189-195; citation_id=CR3
citation_journal_title=Cancer; citation_title=Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community; citation_author=JT Hickok, JA Roscoe, GR Morrow, DK King, JN Atkins, TR Fitch; citation_volume=97; citation_publication_date=2003; citation_pages=2880-2886; citation_doi=10.1002/cncr.11408; citation_id=CR4
citation_journal_title=Eur J Cancer; citation_title=Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy; citation_author=M Watson, L Meyer, A Thomson, S Osofsky; citation_volume=34; citation_publication_date=1998; citation_pages=831-837; citation_doi=10.1016/S0959-8049(97)10146-0; citation_id=CR5
citation_journal_title=Cancer; citation_title=Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings; citation_author=JT Hickok, JA Roscoe, GR Morrow, RM Stern, B Yang, PJ Flynn, HE Hynes, JJ Kirshner, RJ Rosenbluth; citation_volume=86; citation_publication_date=1999; citation_pages=64-71; citation_doi=10.1002/(SICI)1097-0142(19990701)86:1<64::AID-CNCR11>3.0.CO;2-#; citation_id=CR6
citation_journal_title=Int Radiat Oncol Biol Phys; citation_title=Radiation-induced emesis: a prospective observational multicenter Italian trial; citation_author=; citation_volume=44; citation_publication_date=1999; citation_pages=619-625; citation_doi=10.1016/S0360-3016(99)00055-3; citation_id=CR7
citation_journal_title=J Clin Oncol; citation_title=Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trial Group phase III study; citation_author=P Kirkbride, A Bezjak, J Pater, B Zee, MJ Palmer, R Wong, P Cross, S Gulavita, P Blood, A Sun, G Dundas, PK Ganguly, J Lim, AD Chowdhury, SE Kumar, AR Dar; citation_volume=18; citation_publication_date=2000; citation_pages=1960-1966; citation_id=CR8
citation_journal_title=Cancer Investig; citation_title=The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy; citation_author=R Lanciano, DM Sherman, J Michalski, AJ Preston, K Yocom, C Friedman; citation_volume=9; citation_publication_date=2001; citation_pages=763-772; citation_doi=10.1081/CNV-100107736; citation_id=CR9
citation_journal_title=Cancer; citation_title=Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting; citation_author=SP Chawla, SM Grunberg, RJ Gralla, PJ Hesketh, C Rittenberg, ME Elmer, C Schmidt, A Taylor, AD Carides, JK Evans, KJ Horgan; citation_volume=97; citation_issue=9; citation_publication_date=2003; citation_pages=2290-2300; citation_doi=10.1002/cncr.11320; citation_id=CR10
citation_journal_title=Support Care Cancer; citation_title=Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials; citation_author=N Neymark, R Crott; citation_volume=160; citation_publication_date=2005; citation_pages=812-818; citation_doi=10.1007/s00520-005-0803-x; citation_id=CR11
citation_journal_title=J Clin Oncol; citation_title=Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment; citation_author=B Bloechl-Daum, RR Deuson, P Mavros, M Hansen, J Herrstedt; citation_volume=24; citation_issue=27; citation_publication_date=2006; citation_pages=4472-4478; citation_doi=10.1200/JCO.2006.05.6382; citation_id=CR12
citation_journal_title=Support Care Cancer; citation_title=The cost of chemotherapy-induced nausea and vomiting in Italy; citation_author=E Ballatori, F Roila, B Ruggeri, S Porrozzi, M Iannopollo, G Soru, G Cruciani, B Daniele, MC Locatelli, J Pellissier, R Deuson; citation_volume=15; citation_issue=1; citation_publication_date=2007; citation_pages=31-38; citation_doi=10.1007/s00520-006-0094-x; citation_id=CR13
citation_journal_title=Support Care Cancer; citation_title=Chemotherapy-induced nausea and vomiting—incidence and impact on patient quality of life at community oncology settings; citation_author=L Cohen, CA Moor, P Eisenberg, EE Ming, H Hu; citation_volume=15; citation_issue=5; citation_publication_date=2007; citation_pages=497-503; citation_doi=10.1007/s00520-006-0173-z; citation_id=CR14
citation_journal_title=Support Care Cancer; citation_title=The impact of chemotherapy-induced nausea and vomiting on health-related quality of life; citation_author=E Ballatori, F Roila, B Ruggeri, M Betti, S Sarti, G Soru, G Cruciani, M Maio, B Andrea, RR Deuson; citation_volume=15; citation_publication_date=2007; citation_pages=179-185; citation_doi=10.1007/s00520-006-0109-7; citation_id=CR15
citation_journal_title=Cancer; citation_title=Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy; citation_author=Y Tina Shih, Y Xu, LS Elting; citation_volume=110; citation_issue=3; citation_publication_date=2007; citation_pages=678-685; citation_doi=10.1002/cncr.22823; citation_id=CR16
citation_journal_title=Onkologie; citation_title=Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant; citation_author=K Abbrederis, S Lorenzen, N Rothling, A Ihbe-Heffinger, T Schuster, C Peschel, F Lordick; citation_volume=32; citation_issue=1–2; citation_publication_date=2009; citation_pages=30-34; citation_doi=10.1159/000183735; citation_id=CR17
citation_journal_title=J Clin Oncol; citation_title=Determinants of postchemotherapy nausea and vomiting in patients with cancer; citation_author=D Osoba, B Zee, J Pater, D Warr, J Latreille, L Kaizer; citation_volume=15; citation_issue=1; citation_publication_date=1997; citation_pages=116-123; citation_id=CR18
citation_journal_title=Eur J Anaesthesiol; citation_title=Preoperatively administered ramosetron oral disintegrating tablets for preventing nausea and vomiting associated with patient-controlled analgesia in breast cancer patients; citation_author=HJ Lee, JY Kwon, SW Shin, CH Kim, SH Baek, SW Baik, HK Kim, KH Kim; citation_volume=25; citation_issue=9; citation_publication_date=2008; citation_pages=756-762; citation_doi=10.1017/S0265021508004262; citation_id=CR19
citation_journal_title=Support Care Cancer; citation_title=One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient; citation_author=A Enblom, BB Axelsson, G Steineck, M Hammar, S Börjeson; citation_volume=17; citation_publication_date=2009; citation_pages=23-32; citation_doi=10.1007/s00520-008-0445-x; citation_id=CR20
Multinational Association of Supportive Care in Cancer (MASCC) (2008). Antiemetic guidelines (latest update: March 2008)—based on the consensus conference on antiemetic therapy.
http://www.mascc.org/content/127.html
. Accessed 14 Jan 2009
citation_journal_title=Support Care Cancer; citation_title=American Society of Clinical Oncology (ASCO) guideline for antiemetics in oncology: update 2006; citation_author=MG Kris, PJ Hesketh, MR Somerfield, P Feyer, R Clark-Snow, JM Koeller, GR Morrow, LW Chinnery, MJ Chesney, RJ Gralla, SM Grunberg; citation_volume=13; citation_publication_date=2006; citation_pages=80-84; citation_id=CR22
National Comprehensive Cancer Network (NCCN) (2009). NCCN clinical practice guidelines in oncology: antiemesis V.2.2009.
http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf
. Accessed 14 Jan 2009
citation_journal_title=Br J Cancer; citation_title=Behavioural factors influencing the development and expression of chemotherapy induced side effects; citation_author=GR Morrow; citation_volume=66; citation_issue=suppl. XIX; citation_publication_date=1992; citation_pages=S54-S61; citation_id=CR24
citation_journal_title=Support Care Cancer; citation_title=A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre; citation_author=A Molassiotis, MP Saunders, J Valle, G Wilson, P Lorigan, A Wardley, E Levine, R Cowan, J Loncaster, C Rittenberg; citation_volume=16; citation_publication_date=2008; citation_pages=201-208; citation_doi=10.1007/s00520-007-0343-7; citation_id=CR25
citation_journal_title=Cancer; citation_title=Incidence of chemotherapy-induced nausea and emesis after modern antiemetics: perception versus reality; citation_author=SM Grunberg, RR Deuson, P Mavros, O Geling, M Hansen, G Cruciani, B Daniele, G Pouvourville, EB Rubenstein, G Daugaard; citation_volume=100; citation_publication_date=2004; citation_pages=2261-2268; citation_doi=10.1002/cncr.20230; citation_id=CR26
citation_journal_title=J Support Oncol; citation_title=Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study; citation_author=CM Booth, M Clemons, G Dranitsaris, A Joy, S Young, W Callaghan, M Trudeau, T Petrella; citation_volume=5; citation_publication_date=2007; citation_pages=374-380; citation_id=CR27
citation_journal_title=Support Care Cancer; citation_title=Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients; citation_author=A Molassiotis, BMC Yam, H Yung, FYC Chan, TSK Mok; citation_volume=10; citation_publication_date=2002; citation_pages=139-145; citation_doi=10.1007/s00520-001-0321-4; citation_id=CR28
citation_journal_title=Oncologist; citation_title=Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice; citation_author=PJ Hesketh; citation_volume=4; citation_publication_date=1999; citation_pages=191-196; citation_id=CR29
citation_journal_title=Support Care Cancer; citation_title=Emesis induced by low or minimal emetic risk chemotherapy; citation_author=M Tonato, R Clark-Snow, D Osoba, A Favero, E Ballatori, S Borjeson; citation_volume=13; citation_publication_date=2005; citation_pages=109-111; citation_doi=10.1007/s00520-004-0703-5; citation_id=CR30
citation_journal_title=J Natl Cancer Inst; citation_title=The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology; citation_author=NK Aaronson, S Ahmedzai, B Bergman, M Bullinger, A Cull, NJ Duez, A Filiberti, H Flechtner, SB Fleishman, JC Haes; citation_volume=85; citation_publication_date=1993; citation_pages=365-376; citation_doi=10.1093/jnci/85.5.365; citation_id=CR31
citation_journal_title=Qual Life Res; citation_title=Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogenous diagnoses; citation_author=GL Ringdal, K Ringdal; citation_volume=2; citation_publication_date=1993; citation_pages=129-140; citation_doi=10.1007/BF00435732; citation_id=CR32
citation_journal_title=Br J Cancer; citation_title=The development of a method for assessing quality of life of cancer patients; citation_author=PJ Selby, JAW Chapman, J Etazadi-Amoli, NF Boyd; citation_volume=50; citation_publication_date=1984; citation_pages=13-22; citation_doi=10.1038/bjc.1984.134; citation_id=CR33
citation_journal_title=Postgrad Med; citation_title=Screening depressed patients in family practice: a rapid technic; citation_author=AT Beck, RW Beck; citation_volume=52; citation_publication_date=1972; citation_pages=81-85; citation_id=CR34
citation_journal_title=Psychosom Med; citation_title=Impact of event scale: a measure of subjective stress; citation_author=M Horowitz, N Wilner, W Alvarez; citation_volume=41; citation_publication_date=1979; citation_pages=209-18; citation_id=CR35
citation_title=Manual of the Eysenck Personality Questionnaire (revised); citation_publication_date=1991; citation_id=CR36; citation_author=HJ Eysenck; citation_author=SBG Eysenck; citation_publisher=Hodder
citation_title=Cancer incidence and mortality in Western Australia, 1998: a report of the Western Australian Cancer Registry; citation_publication_date=2000; citation_id=CR37; citation_author=TJ Threlfall; citation_author=JR Thompson; citation_publisher=Health Department of Western Australia
citation_journal_title=Ann Oncol; citation_title=Prevention of chemotherapy- and radiotherapy-induced emesis: results of the Perugia consensus conference; citation_author=; citation_volume=9; citation_publication_date=1998; citation_pages=811-819; citation_doi=10.1023/A:1008471812316; citation_id=CR38
citation_journal_title=J Chronic Dis; citation_title=Measuring change over time: assessing the usefulness of evaluative instruments; citation_author=G Guyatt, S Walters, G Norman; citation_volume=40; citation_publication_date=1987; citation_pages=171-178; citation_doi=10.1016/0021-9681(87)90069-5; citation_id=CR39
citation_journal_title=Support Care Cancer; citation_title=Delayed emesis: incidence, pattern, prognostic factors and optimal treatment; citation_author=F Roila, D Donati, S Tamberi, G Margutti; citation_volume=10; citation_publication_date=2002; citation_pages=88-95; citation_doi=10.1007/s005200100295; citation_id=CR40
citation_journal_title=Br J Psychol; citation_title=Anticipatory nausea development in cancer patients: replication and extension of a learning model; citation_author=GR Morrow, J Lindke, PM Black; citation_volume=82; citation_publication_date=1991; citation_pages=61-72; citation_doi=10.1111/j.2044-8295.1991.tb02382.x; citation_id=CR41
citation_journal_title=Auton Neurosci; citation_title=The continuing problem of post chemotherapy nausea and vomiting: contributions of classical conditioning; citation_author=DH Bovbjerg; citation_volume=129; citation_issue=1–2; citation_publication_date=2006; citation_pages=92-98; citation_doi=10.1016/j.autneu.2006.07.016; citation_id=CR42
citation_journal_title=Eur J Oncol Nurs; citation_title=Nausea: the neglected symptom?; citation_author=J Foubert, G Vaessen; citation_volume=9; citation_publication_date=2005; citation_pages=21-32; citation_doi=10.1016/j.ejon.2004.03.006; citation_id=CR43
citation_journal_title=Support Care Cancer; citation_title=Inconsistency of prognostic factors for postchemotherapy nausea and vomiting; citation_author=J Pater, J Slamet, B Zee, D Osoba, D Warr, J Rusthoven; citation_volume=2; citation_publication_date=1994; citation_pages=161-166; citation_doi=10.1007/BF00417474; citation_id=CR44
citation_title=Australian health statistics 2007-08; citation_publication_date=2009; citation_id=CR45; citation_publisher=AIHW
citation_title=Clinical practice guidelines for the psychosocial care of adults with cancer; citation_publication_date=2003; citation_id=CR46; citation_publisher=NBCC
citation_journal_title=Bull Cancer; citation_title=Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination; citation_author=JL Harousseau, R Zittoun, J Bonneterre, M Hedouin, J Ouvry; citation_volume=87; citation_issue=6; citation_publication_date=2000; citation_pages=491-497; citation_id=CR47
citation_journal_title=Cochrane Database Syst Rev; citation_title=Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting (review); citation_author=JM Ezzo, MA Richardson, A Vickers, C Allen, SL Dibble, BF Issell, L Lao, M Pearl, G Ramirez, JA Roscoe, J Shen, JC Shivnan, K Streitberger, I Treish, G Zhang; citation_volume=2; citation_publication_date=2006; citation_pages=1-33; citation_id=CR48
citation_journal_title=Psychooncology; citation_title=The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review; citation_author=K Luebbert, B Dahme, M Hasenbring; citation_volume=10; citation_issue=6; citation_publication_date=2001; citation_pages=490-502; citation_doi=10.1002/pon.537; citation_id=CR49
citation_journal_title=J Clin Oncol; citation_title=Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy; citation_author=DG Warr, PJ Hesketh, RJ Gralla, HB Muss, J Herrstedt, PD Eisenberg, H Raftopoulos, SM Grunberg, M Gabriel, A Rodgers, N Bohidar, G Klinger, CM Hustad, KJ Horgan, F Skobieranda; citation_volume=23; citation_publication_date=2005; citation_pages=2822-2830; citation_doi=10.1200/JCO.2005.09.050; citation_id=CR50